HNN3.0

Project cooperationUpdated on 21 January 2026

Human Collagen and Xeno-free Human ECM for Medical Applications

CEO at Arrakis Bio

Modi'in, Israel

About

Arrakis Bio developed a biomanufacturing platform for producing animal-free Human ECM and Human Collagen, based on human cells in a proprietary bio-reactor system that ensures consistent quality, reproducibility and scalability.

Application areas include - implantable medical devices, drug discovery platforms based on in-vitro NAMs, 3D bioprinting, Tissue regeneration (Bone, Skin, Tendon, Cartilage, etc), Cell therapy, drug delivery, and more.

Topic

  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
  • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-05: Pilot actions for follow-on funding: Leveraging EU-funded collaborative research in regenerative medicine

Type

  • Partner seeks Consortium/Coordinator

Organisation

Arrakis Bio

Start-up

Modi'in, Israel

Similar opportunities